Patents matching “precision”

US 11918571

Compounds and their methods of use

PRAXIS PRECISION MEDICINES, INC. · Granted Mar 5, 2024 · Expires Feb 29, 2044

US 11866439

Ion channel modulators

PRAXIS PRECISION MEDICINES, INC. · Granted Jan 9, 2024 · Expires Jan 4, 2044

US 11866747

Engineered meganucleases that target human mitochondrial genomes

Precision BioSciences, Inc. · Granted Jan 9, 2024 · Expires Jan 4, 2044

US 11851680

Genetically-modified immune cells comprising a microRNA-adapted shRNA (shRNAmiR)

Precision BioSciences, Inc. · Granted Dec 26, 2023 · Expires Dec 21, 2043

US 11826392

Purification method of fungal cell wall composition

HONG SHENG PRECISION BIOTECH CO., LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

US 11788141

MVD as epigenetic marker for the identification of immune cells, in particular CD56+ NK cells

Precision for Medicine GmbH · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11790574

System and method for carbon dioxide angiographic roadmap imaging

GE Precision Healthcare LLC · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11786554

Optimized engineered nucleases having specificity for the human T cell receptor alpha constant region gene

Precision BioSciences, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11788077

Polynucleotides encoding optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome

Precision BioSciences, Inc. · Granted Oct 17, 2023 · Expires Oct 12, 2043

US 11771723

Bifidobacterium longum NCIMB 41676

PrecisionBiotics Group Limited · Granted Oct 3, 2023 · Expires Sep 28, 2043

US 11767367

Monoclonal antibody neo-201 for the treatment of human carcinomas

PRECISION BIOLOGICS, INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

US 11767325

Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators

PRAXIS PRECISION MEDICINES, INC. · Granted Sep 26, 2023 · Expires Sep 21, 2043

US 11753630

Polynucleotides encoding engineered meganucleases having specificity for recognition sequences in the dystrophin gene

Precision BioSciences, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

US 11731978

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

PRAXIS PRECISION MEDICINES, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

US 11731966

Compounds and their methods of use

PRAXIS PRECISION MEDICINES, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

US 11731976

3-(ethoxydifluoromethyl)-6-(5-fluoro-6-(2,2,2-trifluoroethoxy)pyridin-3-yl)-[1,2,4]triazolo[4,3-a]pyridine as an ion channel modulator

PRAXIS PRECISION MEDICINES, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

US 11697669

Hemi-citrate salts of GABA-A positive allosteric modulator and crystalline form thereof

PRAXIS PRECISION MEDICINES, INC. · Granted Jul 11, 2023 · Expires Jul 6, 2043

US 11680254

Engineered meganucleases specific for recognition sequences in the PCSK9 gene

Precision BioSciences, Inc. · Granted Jun 20, 2023 · Expires Jun 15, 2043

US 11679159

Compositions for transfecting resistant cell types

Precision Nanosystems ULC · Granted Jun 20, 2023 · Expires Jun 15, 2043

US 11649207

Formulations of T-type calcium channel modulators and methods of use thereof

PRAXIS PRECISION MEDICINES, INC. · Granted May 16, 2023 · Expires May 11, 2043

US 11629146

Substituted [1,2,4]triazolo[4,3-a]pyrazines as modulators of sodium channel activity

PRAXIS PRECISION MEDICINES, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

US 11590179

Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection

PrecisionBiotics Group Limited · Granted Feb 28, 2023 · Expires Feb 23, 2043

US 11572575

Compositions for transfecting resistant cell types

Precision Nanosystems ULC · Granted Feb 7, 2023 · Expires Feb 2, 2043

US 11572413

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers

PRECISION BIOLOGICS, INC. · Granted Feb 7, 2023 · Expires Feb 2, 2043